title: Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome.
abstract: OBJECTIVE
  To investigate systematically the natural history of visual outcome in nonarteritic anterior ischemic optic neuropathy (NAION).
  
  
  METHODS
  Cohort study.
  
  
  METHODS
  Three hundred forty consecutive untreated patients (386 eyes) with NAION, first seen in our clinic from 1973 to 2000.
  
  
  METHODS
  At first visit, all patients gave a detailed ophthalmic and medical history and underwent a comprehensive ophthalmic evaluation. Visual evaluation was done by recording visual acuity, using the Snellen visual acuity chart, and visual fields with a Goldmann perimeter. The same ophthalmic evaluation was performed at each follow-up visit.
  
  
  METHODS
  Natural history of visual acuity and visual field outcome in NAION.
  
  
  RESULTS
  Of the 386 eyes, 332 had 8 weeks or more of follow-up from the initial visit. At the initial visit, in eyes seen < or =2 weeks from onset of symptoms, 49% had visual acuity of > or =20/30 and 23% had < or =20/200; in these eyes, 38% had minimal to mild visual field defect and 43% marked to severe defect. In those who were first seen < or =2 weeks after onset with visual acuity < or =20/70, there was improvement in 41% at 6 months and in 42% at 1 year after the initial visit. Two years after the initial visit, there was deterioration in 9% of eyes with initial visual acuity of > or =20/60, and in 18% of those with initial visual acuity of < or =20/70. In those who were first seen < or =2 weeks of onset with moderate to severe visual field defect, there was improvement in 26% at 6 months and 27% at 1 year after the initial visit. Two years after the initial visit, 27% of eyes with initial minimal to mild field defects showed worsening, as did 19% of those with moderate to severe defects.
  
  
  CONCLUSIONS
  About half of the eyes with NAION presented with almost normal visual acuity (20/15 to 20/30) at the initial visit. Thus, the presence of normal visual acuity does not rule out NAION. Visual acuity and visual fields showed improvement or further deterioration mainly up to 6 months, with no significant change after that.
authors: Department of Ophthalmology and Visual Sciences, College of Medicine University of Iowa, Iowa City, Iowa, USA. sohan-hayreh@uiowa.edu
authors: Sohan Singh
authors: SS
authors: Hayreh
authors: M Bridget
authors: MB
authors: Zimmerman
mesh_terms: D001167:Arteritis; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D018917:Optic Neuropathy, Ischemic / Q000175:diagnosis* / Q000503:physiopathology; D010211:Papilledema / Q000175:diagnosis; D014786:Vision Disorders / Q000175:diagnosis* / Q000503:physiopathology; D014792:Visual Acuity / Q000502:physiology*; D058609:Visual Field Tests; D014794:Visual Fields / Q000502:physiology*
references: Arch Ophthalmol. 2000 Jun;118(6):793-8
references: 10865316
references: Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1107-21
references: 17219123
references: Ophthalmologica. 2003 Jul-Aug;217(4):239-59
references: 12792130
references: Am J Ophthalmol. 1966 Jul;62(1):103-15
references: 5937141
references: Arch Ophthalmol. 1968 Apr;79(4):400-6
references: 5694282
references: Trans Ophthalmol Soc U K. 1967;87:759-74
references: 5255256
references: Arch Neurol. 1973 Mar;28(3):182-5
references: 4346569
references: Br J Ophthalmol. 1974 Dec;58(12):981-9
references: 4376417
references: Br J Ophthalmol. 1974 Dec;58(12):990-1008
references: 4376418
references: Brain. 1975 Dec;98(4):689-708
references: 1218373
references: Am J Ophthalmol. 1983 Oct;96(4):478-83
references: 6624829
references: Am J Ophthalmol. 1988 Aug 15;106(2):199-203
references: 3400763
references: Am J Ophthalmol. 1988 Oct 15;106(4):443-9
references: 3177563
references: Arch Ophthalmol. 1989 Dec;107(12):1743-54
references: 2597065
references: Eye (Lond). 1990;4 ( Pt 1):25-41
references: 2323477
references: Graefes Arch Clin Exp Ophthalmol. 1990;228(4):281-96
references: 1698170
references: J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):830-3
references: 2266361
references: Arch Ophthalmol. 1991 Dec;109(12):1668-72
references: 1841572
references: Am J Ophthalmol. 1994 May 15;117(5):603-24
references: 8172267
references: J Neuroophthalmol. 1994 Jun;14(2):66-9
references: 7951929
references: JAMA. 1995 Feb 22;273(8):625-32
references: 7844872
references: Am J Ophthalmol. 1997 Mar;123(3):285-96
references: 9063237
references: Ophthalmologica. 1999;213(2):76-96
references: 9885384
references: Eye (Lond). 2004 Nov;18(11):1188-206
references: 15534605
references: Prog Retin Eye Res. 2005 Jul;24(4):493-519
references: 15845346
references: Am J Ophthalmol. 2005 Sep;140(3):376-91
references: 16138997
references: Arch Ophthalmol. 2005 Nov;123(11):1554-62
references: 16286618
references: Ophthalmology. 2007 Sep;114(9):1763-72
references: 17391767
references: Acta Ophthalmol Scand. 2002 Aug;80(4):355-67
references: 12190776